Keyphrases
Mammalian Target of Rapamycin (mTOR)
100%
Immune Response
100%
Neurobehavioral Deficits
100%
Intracerebral Hemorrhage
100%
Mammalian Target of Rapamycin Signaling
33%
Treg
22%
Interferon-α (IFN-α)
11%
Traumatic Brain Injury
11%
Western Blotting
11%
Neurodegenerative Diseases
11%
Neurological Diseases
11%
Transforming Growth Factor-β
11%
Flow Cytometry
11%
Interleukin-10
11%
Striatum
11%
Dysregulated
11%
Serine-threonine Kinase
11%
Peripheral Blood
11%
Rapamycin
11%
Signaling Activation
11%
Intracerebral Injection
11%
Rapamycin Treatment
11%
Cell Growth
11%
Collagenase IV
11%
Modified Neurological Severity Score
11%
Flow-ELISA
11%
CD4+CD25+ Regulatory T Cells
11%
Stroke Disease
11%
Hematoma
11%
Basal Level
11%
Neuroscience
Mammalian Target of Rapamycin
100%
Cerebral Hemorrhage
100%
Interferon
10%
Western Blot
10%
ELISA
10%
Neurodegenerative Disorder
10%
Nervous System Disorder
10%
Transforming Growth Factor
10%
Striatum
10%
T Cell
10%
Interleukin 10
10%
Neurotrauma
10%
Traumatic Brain Injury
10%
Flow Cytometry
10%
Cell Growth
10%
CD4
10%
Protein Serine Threonine Kinase
10%
Hematoma
10%
Collagenase
10%
Pharmacology, Toxicology and Pharmaceutical Science
Mammalian Target of Rapamycin
100%
Brain Hemorrhage
100%
Rapamycin
20%
Bleeding
10%
Cytokine
10%
Interferon
10%
Degenerative Disease
10%
Neurologic Disease
10%
Transforming Growth Factor
10%
Enzyme-Linked Immunosorbent Assay
10%
Western Blot
10%
Flow Cytometry
10%
Traumatic Brain Injury
10%
Interleukin 10
10%
Protein Serine Threonine Kinase
10%
Hematoma
10%
Collagenase
10%